Methods of scar prevention and/or treatment
AssigneeAllergan Pharmaceuticals International Limited
InventorsRobert DANIELS, Damien BATES, John St. Clair ROBERTS
Life of this patent
Estimating the term…
Abstract
The disclosure relates to methods of treating and/or preventing scarring that would otherwise result from an incision to an area of skin. The methods comprise administering a composition comprising tropoelastin to an area of skin that is to receive an incision and/or after the incision. It is also contemplated that the compositions may reduce scar discoloration. Methods of preventing or reducing keloid re-occurrence are also provided.
Claims30
A method of preventing scarring in an area of skin in a subject in need thereof, the method comprising administering a composition comprising tropoelastin to the area of skin that comprises an incision site after the skin has been incised, wherein the composition is administered along a length of the incision site.
A method of preventing scarring or scar discoloration in a subject in need thereof, the method comprising:
- administering a composition comprising tropoelastin to an area of skin comprising an incision site, wherein composition is administered along a length of the incision site about 1 minute to about 365 days after receiving the incision.
A method of treating an area of skin of a subject in need thereof to prevent scar formation or scar coloration, the method comprising:
- administering a composition comprising tropoelastin to the area of skin that has received a fresh wound, wherein the fresh wound is an incision or abrasion.
A method of preventing a keloid in a subject in need thereof, the method comprising:
- administering a composition comprising tropoelastin to an area of skin that has received a wound. wherein the composition is administered about 1 minute, about 1 year, about 2 years, about 3 years, about 4 years, about 5 years, about 6 years, about 7 years, about 8 years, about 9 years or about 10 years after the subject has received a wound, and wherein the subject in need thereof is prone to keloids.
Dependencies are inferred from the claim text.